keyword
https://read.qxmd.com/read/38654029/potassium-augments-growth-yield-nutrient-content-and-drought-tolerance-in-mung-bean-vigna-radiata%C3%A2-l-wilczek
#1
JOURNAL ARTICLE
Mohammad Rafiqul Islam, Umakanta Sarker, Mohammad Golam Azam, Jamil Hossain, Mohammad Ashraful Alam, Riaz Ullah, Ahmed Bari, Nazmul Hossain, Ayman El Sabagh, Mohammad Sohidul Islam
Uneven rainfall and high temperature cause drought in tropical and subtropical regions which is a major challenge to cultivating summer mung bean. Potassium (K), a major essential nutrient of plants can alleviate water stress (WS) tolerance in plants. A field trial was executed under a rainout shelter with additional K fertilization including recommended K fertilizer (RKF) for relieving the harmful impact of drought in response to water use efficiency (WUE), growth, yield attributes, nutrient content, and yield of mung bean at the Regional Agricultural Research Station, BARI, Ishwardi, Pabna in two successive summer season of 2018 and 2019...
April 23, 2024: Scientific Reports
https://read.qxmd.com/read/38648666/best-practice-for-therapeutic-drug-monitoring-of-infliximab-position-statement-from-the-international-association-of-therapeutic-drug-monitoring-and-clinical-toxicology
#2
JOURNAL ARTICLE
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian G Wicha, Gertjan Wolbink, Jo Lambert, Séverine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
BACKGROUND: Infliximab, an anti-tumor necrosis factor monoclonal antibody, has revolutionized the pharmacological management of immune-mediated inflammatory diseases (IMIDs). This position statement critically reviews and examines existing data on therapeutic drug monitoring (TDM) of infliximab in patients with IMIDs. It provides a practical guide on implementing TDM in current clinical practices and outlines priority areas for future research. METHODS: The endorsing TDM of Biologics and Pharmacometrics Committees of the International Association of TDM and Clinical Toxicology collaborated to create this position statement...
April 17, 2024: Therapeutic Drug Monitoring
https://read.qxmd.com/read/38645518/use-of-benzothiophene-ring-to-improve-the-photovoltaic-efficacy-of-cyanopyridinone-based-organic-chromophores-a-dft-study
#3
JOURNAL ARTICLE
Iqra Shafiq, Muhammad Khalid, Gul Maria, Nadeem Raza, Ataualpa A C Braga, Saifullah Bullo, Mohamed Khairy
The benzothiophene based chromophores (A1D1-A1D5) with A-π-A configuration were designed via end-capped tailoring with benzothiophene type acceptors using reference compound (A1R). Quantum chemical calculations were accomplished at M06/6-311G(d,p) level to probe optoelectronic and photophysical properties of designed chromophores. Therefore, frontier molecular orbitals (FMOs), binding energy ( E b ), open circuit voltage ( V oc ), transition density matrix (TDM), density of state (DOS) and UV-Vis analyses of A1R and A1D1-A1D5 were accomplished...
April 16, 2024: RSC Advances
https://read.qxmd.com/read/38639427/microsampling-techniques-suitable-for-therapeutic-drug-monitoring-of-antipsychotics
#4
JOURNAL ARTICLE
Lisanne M Geers, Anton J M Loonen, Daniël J Touw
BACKGROUND: Therapeutic drug monitoring (TDM) of antipsychotics for dose titration or detection of noncompliance is not uncommon in daily practice. Normally, TDM implies measuring a drug concentration in venous blood samples. This technique is invasive and requires trained assistants and patients normally need to go to an outpatient clinic. Over the past decades, sensitivity of analytical equipment has improved leading to a growing interest in microsampling techniques. These techniques are minimally invasive, require a small volume (<100 μL), usually result in stable samples, and can be collected by the patient or a caregiver at home...
April 19, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38622446/preliminary-investigation-of-a-rapid-and-feasible-therapeutic-drug-monitoring-method-for-the-real-time-estimation-of-blood-pazopanib-concentrations
#5
JOURNAL ARTICLE
Masaru Kato, Shinichi Maruyama, Noriko Watanabe, Risa Yamada, Yuki Suzaki, Masaru Ishida, Hiroshi Kanno
Pazopanib is a multi-kinase inhibitor used to treat advanced/metastatic renal cell carcinoma and advanced soft tissue tumors; however, side effects such as diarrhea and hypertension have been reported, and dosage adjustment based on drug concentration in the blood is necessary. However, measuring pazopanib concentrations in blood using the existing methods is time-consuming; and current dosage adjustments are made using the results of blood samples taken at the patient's previous hospital visit (approximately a month prior)...
April 15, 2024: AAPS Journal
https://read.qxmd.com/read/38596317/population-pharmacokinetics-of-gentamicin-in-acute-lymphoblastic-leukemia-pediatric-patients-compared-to-non-oncology-patients
#6
JOURNAL ARTICLE
Hisham S Abou-Auda, Fatimah Alotaibi, Sary Alsanea, Abdulrahman Alwhaibi, Mohammed M Almutairi, Ziyad Alrabiah, Abdullah Alsultan, Majed Al Jeraisy
Understanding the pharmacokinetics of gentamicin is essential in special populations, such as pediatric patients with acute lymphoblastic leukemia (ALL), in light of previous studies indicating that ALL patients have a lower volume of distribution than non-ALL patients. Furthermore, validation of such results is needed to ensure their clinical application. Accordingly, this single-center, retrospective, cross-sectional study compares the pharmacokinetic parameters of volume of distribution and clearance (Cl) of gentamicin between ALL and non-ALL patients...
May 2024: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/38584854/overcoming-provider-barriers-to-therapeutic-drug-monitoring-of-tumour-necrosis-factor-inhibitors-for-rheumatoid-arthritis-a-qualitative-analysis
#7
JOURNAL ARTICLE
Sean P Gavan, Katherine Payne, Anne Barton
OBJECTIVE: Therapeutic drug monitoring (TDM) of tumour necrosis factor-α inhibitors (TNFi), by measuring drug levels and/or anti-drug antibodies, is being considered by various international bodies to improve patient health outcomes and the value of care for people with rheumatoid arthritis. Rheumatology care providers may perceive barriers to adopting TNFi TDM within their own clinical practice, limiting the potential for patients and health care systems to benefit. This study aimed to explore the barriers perceived by rheumatologists that may reduce their uptake of TNFi TDM for rheumatoid arthritis...
2024: Rheumatology Advances in Practice
https://read.qxmd.com/read/38581021/therapeutic-drug-monitoring-of-six-contraindicated-co-administered-drugs-by-simple-and-green-rp-hplc-pda-application-to-spiked-human-plasma
#8
JOURNAL ARTICLE
Nada Hesham, Maha A Hegazy, Hebatallah A Wagdy
Therapeutic drug monitoring is an important clinical testing of the drugs to monitor their concentrations in plasma in order to guarantee their optimal impact, and to avoid any side effects resulting from drug-drug interactions. A green reversed-phase high-performance liquid chromatographic method using a photodiode array detector (RP-HPLC-PDA) was developed for the simultaneous determination of three carbapenem antibiotics (Imipenem, ertapenem, and meropenem) with the co-formulated drug (cilastatin) and contraindicated drugs (probenecid and warfarin) in spiked human plasma...
April 5, 2024: BMC chemistry
https://read.qxmd.com/read/38579409/development-of-a-rapid-lc-ms-ms-method-for-simultaneous-quantification-of-ten-commonly-used-antibiotic-drugs-in-human-serum
#9
JOURNAL ARTICLE
Stefania Ramirez, Margherita Scapaticci, Francesca Barbella, M Marcella Panico, Ileana A Fecca, Barbara Cocchini, Nadia Brizzi, Sonia Cavina, Irene Accorsi, Silvia Rizzato, Eric Ramazzotti, Rita Mancini
The use of TDM in clinical practice to monitor the plasma levels of antibiotics administered to critically ill patients is a well-established approach that allows for optimization of the patient's response to drug therapy, considering the characteristics of the drug, the clinical and physiological status of the patient and any peculiar of the pathogen that caused the clinical picture. In our laboratory, we have developed a single LC-MS/MS analysis for dosing the serum concentration of an antibacterial panel composed of eight antibacterial and two selective inhibitors...
March 30, 2024: Journal of Pharmaceutical and Biomedical Analysis
https://read.qxmd.com/read/38576184/therapeutic-drug-monitoring-of-6-new-generation-antiseizure-medications-using-a-mass-spectrometry-method-analysis-of-2-year-experience-in-a-large-cohort-of-korean-epilepsy-patients
#10
JOURNAL ARTICLE
Sang-Mi Kim, Won Young Heo, Hyeonju Oh, Eun Yeon Joo, Young-Min Shon, Seung Bong Hong, Soo-Youn Lee, Dae-Won Seo
CONTEXT.—: New-generation antiseizure medications (ASMs) are increasingly prescribed, and therapeutic drug monitoring (TDM) has been proposed to improve clinical outcome. However, clinical TDM data on new-generation ASMs are scarce. OBJECTIVE.—: To develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for therapeutic drug monitoring (TDM) of 6 new-generation ASMs in serum and analyze the clinical TDM data from a large cohort of Korean patients with epilepsy...
April 5, 2024: Archives of Pathology & Laboratory Medicine
https://read.qxmd.com/read/38574874/development-validation-and-clinical-application-of-a-uplc-ms-ms-method-for-omadacycline-determination-in-human-serum
#11
JOURNAL ARTICLE
Guo Suhang, Zheng Ren, Fan Xudong, Zhang Ruoying, Cai Xinjun, Jin Jie
BACKGROUND: Omadacycline is the first aminomethyl-tetracycline variety to successfully enter clinical applications. To support regular therapeutic drug monitoring (TDM) in clinical practice, an ultra-high-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) method was developed that would allow omadacycline quantification in human serum. METHODS: Proteins were precipitated from serum samples using methanol. Tigecycline was used as the internal standard...
April 2, 2024: Journal of Pharmacological and Toxicological Methods
https://read.qxmd.com/read/38569058/influence-of-ultrafiltration-conditions-on-the-measurement-of-unbound-drug-concentrations-flucloxacillin-as-an-example
#12
JOURNAL ARTICLE
Nynke G L Jager, Eleonora Van Ewijk-Beneken Kolmer, Rob Aarnoutse, Lindsey H M Te Brake
BACKGROUND: When performing therapeutic drug monitoring (TDM) for flucloxacillin, it is advised to measure the unbound, not the total, flucloxacillin concentration. To be able to accurately quantify unbound flucloxacillin concentrations, a reliable analytical method is indispensable. OBJECTIVE: To determine the influence of temperature and pH of the sample during ultrafiltration on the measured unbound fraction of flucloxacillin. MATERIALS AND METHODS: We performed three different experiments...
April 3, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38565898/assessment-of-the-practical-impact-of-adjusting-beta-lactam-dosages-based-on-therapeutic-drug-monitoring-in-critically-ill-adult-patients-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials-and-observational-studies
#13
JOURNAL ARTICLE
Eszter Gulyás, István László Horváth, Marie Anne Engh, Stefania Bunduc, Fanni Dembrovszky, Péter Fehérvári, András Bánvölgyi, Dezső Csupor, Péter Hegyi, Gellért Balázs Karvaly
An estimated 70% of critically ill patients receive antibiotics, most frequently beta-lactams. The pharmacokinetic properties of these substances in this patient population are poorly predictable. Therapeutic drug monitoring (TDM) is helpful in making personalized decisions in this field, but its overall impact as a clinical decision-supporting tool is debated. We aimed to evaluate the clinical implications of adjusting beta-lactam dosages based on TDM in the critically ill population by performing a systematic review and meta-analysis of available investigations...
April 2, 2024: Scientific Reports
https://read.qxmd.com/read/38565831/total-valproate-versus-free-valproate-in-therapeutic-drug-monitoring-for-bipolar-disorder-a-cross-sectional-study
#14
JOURNAL ARTICLE
Mullezhath Babu Nimesh Krishna, Jyothsna Chinnapura Seetharam, Archana Mishra, Rituparna Maiti, Biswa Ranjan Mishra, Anand Srinivasan
INTRODUCTION: The debate about observing total versus free serum valproate levels for therapeutic drug monitoring (TDM) has been unresolved for decades. This study was planned to assess the agreement between the total versus free valproate levels and the advantage of one method over the other in TDM. METHODS: The present cross-sectional study was done on 93 patients with bipolar disorder. The intraclass correlation coefficient, Bland Altman analysis, and Lin's concordance analysis were done to assess the agreement between the total and free valproate concentrations...
June 2024: Asia-Pacific Psychiatry: Official Journal of the Pacific Rim College of Psychiatrists
https://read.qxmd.com/read/38560631/ataxia-and-seizures-despite-phenytoin-a-case-report-highlighting-the-importance-of-tdm-and-genetic-influences
#15
Rachel Manoj, Arpita Meher, Jefry Winner G
Adverse drug reactions to commonly prescribed medications such as phenytoin, used for seizures, often go undetected due to various factors. This case report highlights a 52-year-old male diagnosed with late-onset epilepsy who was prescribed phenytoin. Despite the standard dosage, the patient experienced toxicity symptoms and a seizure, prompting admission for assessment. Laboratory tests and imaging were inconclusive, leading to a therapeutic drug monitoring (TDM) consultation, which revealed elevated phenytoin levels...
2024: Case Reports in Neurological Medicine
https://read.qxmd.com/read/38555681/therapeutic-drug-monitoring-for-tyrosine-kinase-inhibitors-in-metastatic-renal-cell-carcinoma
#16
REVIEW
Jakob N Henriksen, Charlotte U Andersen, Niels Fristrup
Inter-individual variability in drug response pose significant challenges to treatment with tyrosine kinase inhibitors (TKIs) in patients with metastatic renal cell carcinoma (mRCC). TKIs meet traditional criteria for using therapeutic drug monitoring (TDM), but research is still limited. Understanding the role of TDM in individualizing treatment strategies could help optimize treatment. Here we review the state of knowledge of TDM for TKIs in mRCC treatment. A comprehensive literature review of original research studies focusing on TDM of TKIs in mRCC treatment, clinical in vivo studies reporting on pharmacokinetics-pharmacodynamics, therapeutic ranges, drug concentrations, dose adjustments, clinical outcomes, or other relevant aspects related to TDM...
March 8, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38547701/simultaneous-determination-of-11-oral-targeted-antineoplastic-drugs-and-2-active-metabolites-by-lc-ms-ms-in-human-plasma-and-its-application-to-therapeutic-drug-monitoring-in-cancer-patients
#17
JOURNAL ARTICLE
Jing Zhao, Dongming Yan, Yue Li, Xiaoqing Xu, Fengling Li, Shuang Zhang, Jingyi Jin, Furong Qiu
Interindividual exposure differences have been identified in oral targeted antineoplastic drugs (OADs) owing to the pharmacogenetic background of the patients and their susceptibility to multiple factors, resulting in insufficient efficacy or adverse effects. Therapeutic drug monitoring (TDM) can prevent sub-optimal concentrations of OADs and improve their clinical treatment. This study aimed to develop and validate an LC-MS/MS method for the simultaneous quantification of 11 OADs (gefitinib, imatinib, lenvatinib, regorafenib, everolimus, osimertinib, sunitinib, tamoxifen, lapatinib, fruquintinib and sorafenib) and 2 active metabolites (N-desethyl sunitinib and Z-endoxifen) in human plasma...
March 26, 2024: Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
https://read.qxmd.com/read/38547661/population-pharmacokinetics-of-everolimus-in-renal-transplant-recipients-receiving-long-term-multiple-immunosuppressive-therapy
#18
JOURNAL ARTICLE
Tomoyuki Sakaue, Kazuhiro Yamamoto, Kotaro Itohara, Yumi Kitahiro, Takahito Endo, Naoki Yokoyama, Takeshi Ishimura, Tomohiro Omura, Ikuko Yano
Everolimus is used for immunosuppression after renal transplantation. This study aimed to develop a population pharmacokinetic (PopPK) model of everolimus using therapeutic drug monitoring (TDM) data of patients under long-term multiple immunosuppressive therapy, including tacrolimus. To develop the model, 185 renal transplant recipients with 3358 everolimus blood concentrations during a median postoperative period of 35.3 months were included. The PopPK model is described as a one-compartment model with first-order absorption...
March 12, 2024: Drug Metabolism and Pharmacokinetics
https://read.qxmd.com/read/38546915/effects-of-several-auxiliary-acceptors-and-anchoring-groups-on-charge-transfer-and-photophysical-properties-of-d-a-%C3%AF-a-type-dsscs-a-dft-study
#19
JOURNAL ARTICLE
Mingjianshuo Gong, Lingpeng Zeng, Wenbo Wang, Xuanchen Dong, Zhenshuo Yu, Songhao Wang, Yi Yang
In this paper, we performed theoretical studies on the twelve D-A-π-A type organic dyes (G-1 ~ G-3, M-1 ~ M-3, J-1 ~ J-3, and S-1 ~ S-3) with 9-phenylcarbazole as the electron donor in anticipation of the application of these dyes in dye-sensitized solar cells (DSSCs). DFT and TD-DFT methods are applied to investigate in detail the molecular geometries, frontier molecular orbitals (FMOs), absorption spectra, charge density difference (CDD), and transition density matrix (TDM) of several dyes...
March 28, 2024: Journal of Fluorescence
https://read.qxmd.com/read/38545548/emerging-therapeutic-drug-monitoring-technologies-considerations-and-opportunities-in-precision-medicine
#20
REVIEW
Winnie S Liang, Brett Beaulieu-Jones, Susan Smalley, Michael Snyder, Laura H Goetz, Nicholas J Schork
In recent years, the development of sensor and wearable technologies have led to their increased adoption in clinical and health monitoring settings. One area that is in early, but promising, stages of development is the use of biosensors for therapeutic drug monitoring (TDM). Traditionally, TDM could only be performed in certified laboratories and was used in specific scenarios to optimize drug dosage based on measurement of plasma/blood drug concentrations. Although TDM has been typically pursued in settings involving medications that are challenging to manage, the basic approach is useful for characterizing drug activity...
2024: Frontiers in Pharmacology
keyword
keyword
76346
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.